20 gynecological Chinese patent medicine into pharmacies sweet and pastry!

Recently, Tasly issued an announcement stating that the company's exclusive category of Chinese medicine 1.

Tasly's blockbuster Class 1 new drug strikes, only 2 gynecological Chinese patent medicines have been approved in the past 3 years

Basic situation of Kunxinning granules

Recently, Tasly issued an announcement stating that the company's exclusive variety of Chinese medicine 1.

According to the data, according to the "Consensus of Experts on the Management of Menopausal Women's Health (Basic Version)", the current medical treatment of menopausal syndrome is mainly divided into two categories: Chinese medicine treatment and menopausal hormone treatment.

Gynecological Chinese patent medicines approved since 2019

Source: Meinenet MED2.

Since 2019, only two products of Guangzhou Kangyuan Pharmaceutical's Jinrong Xiaopi Granules and Tasly's Kunxinning Granules have been approved for marketing in Chinese patent medicines for gynecology

"Beijing, Shanghai, Guangzhou and Shenzhen" has the hottest sales! Qianjin, Guangyuyuan and Enwei "Leader" the retail market of Chinese patent medicines in gynecology

2021E city layout of gynecological Chinese patent medicines in physical pharmacies in key cities (unit: ten thousand yuan)

Source: Mi Nei.

According to data from Mi Nei.

From the perspective of manufacturers, Zhuzhou Qianjin Pharmaceutical, Shanxi Guangyuyuan Sinopharm, Sichuan Enwei Pharmaceutical, Beijing Tongrentang Co.

Sub-category of gynecological Chinese patent medicines in physical pharmacies in key cities in 2021E

Source: Mi Nei.

In terms of sub-categories, gynecological inflammation drugs and gynecological menstrual regulation drugs have been the two main forces for many years, with a total market share of more than 80%

11 exclusive products seize the TOP20, four major brands are dazzling

2021E TOP20 gynecological Chinese patent medicine products in physical pharmacies in key cities

Source: Mi Nei.

Note: * is exclusive

Among the TOP20 products, 11 are exclusive products, involving 9 pharmaceutical companies including Zhuzhou Qianjin Pharmaceutical, Sichuan Enwei Pharmaceutical, Shandong Buchang Shenzhou Pharmaceutical, Hainan Bikai Pharmaceutical, and Guiyang Xintian Pharmaceutical

In terms of growth rate, Zishen Yutai Pills, Kuntai Capsules, Jinfeng Pills, and Kushen Gel all exceeded 20%.

2021E: TOP20 gynecological Chinese patent medicine brands in physical pharmacies in key cities

Source: Mi Nei.

Among the TOP20 brands, Dingkundan of Shanxi Guangyuyuan National Medicines, Jieryin Lotion of Sichuan Enwei Pharmaceutical, and Baofukang Suppository of Hainan Bikai Pharmaceutical are ranked in the top three; in terms of the number of brands, Zhuzhou Qianjin Pharmaceutical There are 4 at most, and Jiawei Xiaoyao pills have been added compared to last year

Zishen Yutai Pills is the exclusive gynecological Chinese patent medicine of Baiyunshan Zhongyi Pharmaceutical.

Among the TOP20 brands, Zhuzhou Qianjin Pharmaceutical has 4 products on the list, including Gynecological Qianjin Tablets, Gynecological Qianjin Capsules, Yimu Granules, and Jiawei Xiaoyao Pills.
Among them, Gynecological Qianjin Tablets and Gynecological Qianjin Capsules are exclusive products
.
According to data from Mi Nei.
com, the market share of gynecological Qianjin tablets in physical pharmacies in key cities has steadily increased in recent years
.
In addition, Zhuzhou Qianjin Pharmaceutical's Jiawei Xiaoyao Pills ranked among the TOP20 brands, with sales increasing by nearly 15% year-on-year
.
Qianjin Pharmaceutical pointed out in the 2021 semi-annual report that for retail terminals, the company’s pharmacy marketing department has strengthened cooperation with chain pharmacies and individual pharmacies across the country, and formulated different cooperation plans based on the characteristics of chain pharmacies to meet the needs of chain differentiation.
Through channel distribution to ensure that products reach various retail terminals
.
Through intensified consumer education, store staff training, brand promotion and other store promotion activities, the company will continue to maintain steady growth at the retail end in the first half of 2021
.
In addition to gynecological Qianjin tablets/capsules, products such as Yimu Granules and Jiawei Xiaoyao Pills have grown rapidly at the retail end, and their market position has been further strengthened
.

Source: Minet.
com database, company announcement

Note: The terminal competition pattern of physical pharmacies in key cities of Minai.
com is based on the sales data of all physical pharmacies in 22 key cities, including Beijing, Shanghai, Guangzhou, and Shenzhen, and is a sample city drug database that continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product at the terminal
.
Please correct me if there are any errors or omissions
.